期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 54, 期 9, 页码 3988-3990出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00067-10
关键词
-
资金
- Human Frontiers Science Program [RGY0069/2008-C]
- DARPA
- USDA [WIS00974]
- Searle Scholar Award
Bacterial cytoskeletal proteins are an emerging set of targets for antibiotic development. This paper describes oligochlorophen analogs based on the monomer 4-chloro-2,6-dimethylphenol as antimicrobial agents against Bacillus anthracis. The most potent analogs have a MIC of 160 to 320 nM against B. anthracis and may target the cytoskeletal protein FtsZ. B. anthracis develops resistance to the oligochlorophens at a rate of 4.34 x 10(-10) per generation, which is similar to 10-fold lower than that of commercial antibiotics used to treat this human pathogen.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据